$PMVP PMV Pharmaceuticals, Inc. Insider Trading Week 23/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PMV Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PMV Pharmaceuticals, Inc. in week 23/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 585 | 19,118 | 129,980 | 130.6 K to 130 K (-0.45 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 11,485 | 375,330 | 2,533,517 | 2.5 M to 2.5 M (-0.45 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 3,317 | 108,400 | 731,673 | 735 K to 731.7 K (-0.45 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 3,063 | 100,099 | 675,551 | 678.6 K to 675.6 K (-0.45 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 32.68 | 2,183 | 71,340 | 481,386 | 483.6 K to 481.4 K (-0.45 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 1,121 | 37,710 | 129,565 | 130.7 K to 129.6 K (-0.86 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 22,070 | 742,435 | 2,545,002 | 2.6 M to 2.5 M (-0.86 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 6,372 | 214,354 | 734,990 | 741.4 K to 735 K (-0.86 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 5,883 | 197,904 | 678,614 | 684.5 K to 678.6 K (-0.86 %) |
| Jun 11 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.64 | 4,192 | 141,019 | 483,569 | 487.8 K to 483.6 K (-0.86 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 896 | 29,908 | 130,686 | 131.6 K to 130.7 K (-0.68 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 17,664 | 589,624 | 2,567,072 | 2.6 M to 2.6 M (-0.68 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 5,101 | 170,271 | 741,362 | 746.5 K to 741.4 K (-0.68 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 4,708 | 157,153 | 684,497 | 689.2 K to 684.5 K (-0.68 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.38 | 3,355 | 111,990 | 487,761 | 491.1 K to 487.8 K (-0.68 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 1,019 | 34,259 | 131,582 | 132.6 K to 131.6 K (-0.77 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 16,901 | 568,212 | 2,584,736 | 2.6 M to 2.6 M (-0.65 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 4,946 | 166,285 | 746,463 | 751.4 K to 746.5 K (-0.66 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 4,564 | 153,442 | 689,205 | 693.8 K to 689.2 K (-0.66 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | 10% Owner | Sell | S | 33.62 | 3,291 | 110,643 | 491,116 | 494.4 K to 491.1 K (-0.67 %) |
| Jun 09 2021 | PMVP | PMV Pharmaceutical ... | Stelzer Laurie | Director | Option Exercise | A | 32.29 | 16,333 | 527,393 | 16,333 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Jalota Deepika | SVP, Regulatory Aff ... | Option Exercise | A | 28.33 | 22,674 | 642,354 | 22,674 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 365,850 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | A | 28.33 | 36,279 | 1,027,784 | 36,279 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 34.00 | 1,367 | 46,484 | 0 | 1.4 K to 0 (-100.00 %) |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 33.39 | 2,633 | 87,903 | 1,367 | 4 K to 1.4 K (-65.82 %) |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Buy | M | 3.90 | 4,000 | 15,600 | 4,000 | 0 to 4 K |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Mack David Henry | President and CEO | Option Exercise | A | 28.33 | 134,584 | 3,812,765 | 134,584 |